Clinical Trial Update: R3® Acetabular System in Patients With Degenerative Hip Disease

View source ↗

Summary

The R3 Acetabular System trial in patients with degenerative hip disease has completed. The sponsor is Smith & Nephew, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• R3 Acetabular System

Snippet

Sponsor: Smith & Nephew, Inc. | Conditions: Osteoarthritis | Status: COMPLETED